ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,253, issued on Nov. 18, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).
"Activin a antibody formulations and methods of use thereof" was invented by Douglas Kamen (Poughquag, N.Y.) and Kenneth Graham (Pleasant Valley, N.Y.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides novel pharmaceutical formulations comprising an antibody that specifically binds to human Activin A. The formulations may contain, in addition to an anti-Activin A antibody, a histidine buffer, an organic cosolvent, and a thermal stabilizer. The pharmaceutical formulations of the present invention exhibit a surprising degree of antibody...